Skip to main content
. 2016 Nov 25;8(3):4875–4887. doi: 10.18632/oncotarget.13608

Table 3. Protein expression in patients with tissue available.

Patients, n (%)
AR Nuclear (low/high) 44 (47.8)/ 45 (48.9)
AR Cytoplasmic (low/high) 45 (48.9)/ 44 (47.8)
pARS578 Nuclear (low/high) 30 (32.6)/ 30 (32.6)
pARS578 Cytoplasmic (low/high) 32 (34.8)/ 28 (30.4)
PKC Nuclear (low/high) 30 (32.6)/ 28 (30.4)
PKC Cytoplasmic (low/high) 29 (31.5)/ 29 (31.5)
pPKC Nuclear (low/high) 41 (44.6)/ 40 (43.5)
pPKC Cytoplasmic (low/high) 41 (44.6)/ 40 (43.5)

The proteins of interest were grouped as ≤median or >median. Number of patients with missing data is not displayed. Values that do not give a sum of 100% is due to data being unavailable.